Introduction of vagus nerve stimulation into a maintenance electroconvulsive therapy regimen: A case study and cost analysis

Journal of ECT

Volumn 23, Issue 2, 2007, Pages 114-119

  Warnell, Ronald L ^a,b   Elahi, Nazanin ^a  

^a LOMA LINDA UNIVERSITY   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Electroconvulsive therapy; Treatment resistant depression; Vagus nerve stimulation

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ATOMOXETINE; ATORVASTATIN; CITALOPRAM; ESCITALOPRAM; ESMOLOL; FEXOFENADINE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; LAMOTRIGINE; LEVOTHYROXINE; LISINOPRIL; LITHIUM CARBONATE; LORAZEPAM; MIDAZOLAM; MIRTAZAPINE; MODAFINIL; OLANZAPINE; PAROXETINE; RISPERIDONE; SERTRALINE; VENLAFAXINE; ZIPRASIDONE;

ADULT; AGITATION; ARTICLE; BIPOLAR DISORDER; CASE REPORT; COST BENEFIT ANALYSIS; COST CONTROL; DEPRESSION; DEVICE; ELECTROCONVULSIVE THERAPY; HUMAN; HYPERTENSION; HYPOTHYROIDISM; IMPLANTATION; LABORATORY TEST; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PSYCHOTHERAPY; VAGUS NERVE STIMULATION;

ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; COMBINED MODALITY THERAPY; COSTS AND COST ANALYSIS; DEPRESSION; ELECTRIC STIMULATION THERAPY; ELECTROCONVULSIVE THERAPY; HUMANS; MALE; MIDDLE AGED; VAGUS NERVE;

EID: 34249872469     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e3180616647     Document Type: Article

References (51)

1. Abrams R. Electroconvulsive Therapy. New York, NY: Oxford University Press; 2002;159:17-42.
2. Andrade C, Kurinji S. Continuation and maintenance ECT: a review of recent research. J ECT. 2002;18:149-158.
3. Schwarz T, Lowenstein J, Isenberg KE. Maintenance ECT: indications and outcome. Convuls Ther. 1995;11:14-23.
4. American Psychiatric Association. Practice guidelines for the treatment of patients with major depressive disorder (revision). Am J Psychiatry. 2000;157(suppl 4):1-45.
5. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. 2nd ed. Washington, DC: American Psychiatric Association; 2001:5-25.
6. Prudic J, Haskett RF, Mulsant B, et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry. 1996;153:985-992.
7. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389.
8. Hawley CJ, Gale TM, Sivakumaran T, et al. Defining remission by cut off score on the MADRS: selecting the optimal value. J Affect Disord. 2002;72:177-184.
9. Carmody TJ, Rush AJ, Bernstein IH, et al. Making clinicians live easier: guidance on use of the QIDS self-report in place of the MADRS. J Affect Disord. 2006;95:115-118.
10. Physician's Manual. VNS Therapy™ Pulse Model 102 Generator and VNS Therapy™ Pulse Duo Model 102R Generator. Available at: http://www.vnstherapy.com/manuals/doc_download.asp?docid={E5D2100B-A4C2-409B- B71C-E1CEA60FBD90}. Accessed October 27, 2005.
11. Husain MM, Montgomery JH, Fernandes P, et al. Safety of vagus nerve stimulation with ECT (letter). Am J Psychiatry. 2002;159:1243.
12. Burke MJ, Husain MM. Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression. J ECT. 2006;22:218-222.
13. Sackeim HA, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology. 2001;25:713-728.
14. Rush AJ, Sackeim HA, Marangell LB, et al. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry. 2005;58:355-363.
15. Wade A, Despiegel N, Reines EH. Escitalopram in the long-term treatment of major depressive disorder. Ann Clin Psychiatry. 2006;18:83-89.
16. Corya SA, Perlis RH, Keck PE Jr, et al. A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression. J Clin Psychiatry. 2006;67:798-806.
17. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
18. Ware JE Jr, Kosinski M. SF-36® Physical and Mental Health Summary Scales: A Manual for Users of Version 1. 2nd ed. Lincoln, RI: QualityMetric Inc; 2005.
19. Swoboda E, Conca A, Konig P, et al. Maintenance electroconvulsive therapy in affective and schizoaffective disorder. Neuropsychobiology. 2001;43:23-28.
20. Aziz M, Mehringer AM, Mozurkewich E, et al. Cost-utility of 2 maintenance treatments for older adults with depression who responded to a course of electroconvulsive therapy: results from a decision analytic model. Can J Psychiatry. 2005;50:389-397.
21. Russell JC, Rasmussen KG, O'Connor MK, et al. Long-term maintenance ECT: a retrospective review of efficacy and cognitive outcome. J ECT. 2003;19:4-9.
22. Gagne GG, Furman MJ, Carpenter LL, et al. Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am J Psychiatry. 2000;157:1960-1965.
23. Rabheru K, Persad E. A review of continuation and maintenance electroconvulsive therapy. Can J Psychiatry. 1997;42:476-484.
24. Petrides G, Dhossche D, Fink M, et al. Continuation ECT: relapse prevention in affective disorders. Convuls Ther. 1994;10:189-194.
25. Vanelle J-M, Loo H, Galinowski A, et al. Maintenance ECT in intractable manic-depressive disorders. Convuls Ther. 1994;10:195-205.
26. Kramer BA. A seasonal schedule for maintenance ECT. J ECT. 1999;15:226-231.
27. Kramer BA. A naturalistic review of maintenance ECT at a university setting. J ECT. 1999;15:262-269.
28. Abraham G, Milev R, Delva N, et al. Clinical outcome and memory function with maintenance electroconvulsive therapy: a retrospective study. J ECT. 2006;22:43-45.
29. Clarke TB, Coffey CE, Hoffman GW, et al. Continuation therapy for depression using outpatient electroconvulsive therapy. Convuls Ther. 1989;5:330-337.
30. Frederikse M, Petrides G, Kellner C. Continuation and maintenance electroconvulsive therapy for the treatment of depressive illness: a response to the National Institute for Clinical Excellence Report. J ECT. 2006;22:13-17.
31. Jarvis MR, Zorumski CF, Goewert AJ, et al. Maintenance electroconvulsive therapy and seizure duration. Convuls Ther. 1993;9:8-13.
32. Stiebel VG. Maintenance electroconvulsive therapy for chronic mentally ill patients: a case series. Psychiatr Serv. 1995;46:265-268.
33. Thienhaus OJ, Margletta S, Bennet JA. A study of clinical efficacy of maintenance ECT. J Clin Psychiatry. 1990;51:485-486.
34. Thornton JE, Mulsant BH, Dealy R, et al. A retrospective study of maintenance electroconvulsive therapy in a university-based psychiatric practice. Convuls Ther. 1990;6:121-129.
35. Vaidya NA, Mahableshwarkar AR, Shahid R. Continuation and maintenance ECT in treatment-resistant bipolar disorder. J ECT. 2003;19:10-16.
36. Vothknecht S, Kho KH, van Schaick HW, et al. Effects of maintenance electroconvulsive therapy on cognitive functions. J ECT. 2003;19:151-157.
37. Wijkstra J, Nolen WA. Successful maintenance electroconvulsive therapy for more than seven years. J ECT. 2005;21:171-173.
38. Loo H, Galinowski A, de Carvalho W, et al. Use of maintenance ECT for elderly depressed patients (letter). Am J Psychiatry. 1991;148:810.
39. McDonald WM. Is ECT cost-effective? A critique of the National Institute of Health and Clinical Excellence's report on the economic analysis of ECT. J ECT. 2006;22:25-29.
40. Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry. 2006;63:1337-1344.
41. Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry. 2003;64:1465-1475.
42. Greenberg PE, Stiglin LE, Finkelstein SN, et al. The economic burden of depression in 1990. J Clin Psychiatry. 1993;54:405-418.
43. Druss BG, Rosenheck RA, Sledge WH. Health and disability costs of depressive illness in a major US corporation. Am J Psychiatry. 2000;157:1274-1278.
44. Dunner DL, Rush AJ, Russell JM, et al. Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression. J Clin Psychiatry. 2006;67:688-695.
45. Bonds C, Frye MA, Coudreaut MF, et al. Cost reduction with maintenance ECT in refractory bipolar disorder. J ECT. 1998;14:36-41.
46. Steffens DC, Krystal AD, Sibert TE, et al. Cost effectiveness of maintenance ECT (letter). Convuls Ther. 1995;11:283-284.
47. American Psychiatric Association. Electroconvulsive Therapy. Available at: www.psych.org/research/apire/training_fund/clinzres/index.cfm. Accessed September 23, 2006.
48. California Office of Statewide Health Planning and Development Healthcare Information Division. Available at: http://www.oshpd. cahwnet.gov/HID/hospital/ finance/faqshospfin.htm#Q15. Accessed September 23, 2006.
49. Sackeim HA, Sackeim SK, Rush AJ, et al. Durability of antidepressant response to vagus nerve stimulation (VNS™). Int J Neuropsychopharm. 2007;doi:10.1017/S1461145706007425.
50. Nahas Z, Marangell LB, Husain MM, et al. Two-year outcomes of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry. 2005;66:1097-1104.
51. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001;285:1299-1307.